Literature DB >> 28042374

Cbl ubiquitin ligases mediate the inhibition of natural killer cell activity.

Omri Matalon1, Mira Barda-Saad1.   

Abstract

Natural killer (NK) cells are essential for killing transformed and virally infected cells. To prevent auto-reactivity, NK cell activation is inhibited by inhibitory receptors that activate the tyrosine phosphatase SHP-1, which dephosphorylates signaling molecules crucial for NK cell activation. Initially, only a single SHP-1 substrate was identified in NK cells, the GEF VAV1. We recently demonstrated that under inhibitory conditions, LAT, PLCγ1 and PLCγ2 serve as novel SHP-1 substrates in NK cells. Furthermore, we showed that during NK cell inhibition, LAT is ubiquitylated by c-Cbl and Cbl-b, leading to its proteasomal degradation, abolishing NK cell cytotoxicity. Here, we address the mechanism through which the Cbl proteins are activated following inhibitory receptor engagement. We demonstrate that during NK cell inhibition, the expression level of the Cbl proteins significantly increases. These data suggest that inhibitory KIR receptors regulate the stability of the Cbl proteins, thereby enabling Cbl-mediated inhibition of NK cell cytotoxicity.

Entities:  

Keywords:  Cbl-b; E3 ubiquitin ligase; NK cell inhibition; NK cell signaling; c-Cbl; cytotoxicity; natural killer cells; ubiquitylation

Year:  2016        PMID: 28042374      PMCID: PMC5193043          DOI: 10.1080/19420889.2016.1216739

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


  23 in total

1.  Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement.

Authors:  R Paolini; R Molfetta; M Piccoli; L Frati; A Santoni
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

2.  Ubiquitylation-dependent negative regulation of WASp is essential for actin cytoskeleton dynamics.

Authors:  Barak Reicher; Noah Joseph; Ahuvit David; Maor H Pauker; Orly Perl; Mira Barda-Saad
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

3.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

Review 4.  Proteolysis: from the lysosome to ubiquitin and the proteasome.

Authors:  Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

Review 5.  Calcium signaling.

Authors:  David E Clapham
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 6.  Inhibitory and regulatory immune synapses.

Authors:  Philipp Eissmann; Daniel M Davis
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation.

Authors:  W Zhang; J Sloan-Lancaster; J Kitchen; R P Trible; L E Samelson
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

Review 8.  Wiskott-Aldrich syndrome protein--dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes.

Authors:  Omri Matalon; Barak Reicher; Mira Barda-Saad
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

9.  Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.

Authors:  Ilaria Tassi; Rachel Presti; Sungjin Kim; Wayne M Yokoyama; Susan Gilfillan; Marco Colonna
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

10.  Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains.

Authors:  Alex Braiman; Mira Barda-Saad; Connie L Sommers; Lawrence E Samelson
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

View more
  6 in total

Review 1.  E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.

Authors:  D Jafari; M J Mousavi; S Keshavarz Shahbaz; L Jafarzadeh; S Tahmasebi; J Spoor; A Esmaeilzadeh
Journal:  Clin Exp Immunol       Date:  2021-01-10       Impact factor: 5.732

2.  Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells.

Authors:  Ting Lu; Li Chen; Anthony G Mansour; Melissa J Yu; Noah Brooks; Kun-Yu Teng; Zhenlong Li; Jianying Zhang; Tasha Barr; Jianhua Yu; Michael A Caligiuri
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.426

3.  Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma.

Authors:  Qian Dong; Yuteng Ma; Yao Zhang; Xiujuan Qu; Zhi Li; Yafei Qi; Yunpeng Liu; Ce Li; Kai Li; Xianghong Yang; Xiaofang Che
Journal:  Oncotarget       Date:  2017-06-27

4.  Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells.

Authors:  Sridharan Ganesan; Petter Höglund
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

5.  CBLB ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy.

Authors:  Xuan Guo; Tanel Mahlakõiv; Qian Ye; Srinivas Somanchi; Shuyang He; Hemlata Rana; Andrea DiFiglia; Joseph Gleason; William van der Touw; Robert Hariri; Xiaokui Zhang
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

Review 6.  Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Authors:  Antonio Valeri; Almudena García-Ortiz; Eva Castellano; Laura Córdoba; Elena Maroto-Martín; Jessica Encinas; Alejandra Leivas; Paula Río; Joaquín Martínez-López
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.